title: [Biliary sludge: diagnosis and treatment at an outpatient's clinic].
abstract: The purpose of the study--to develop a diagnostic and management tactics for patients with biliary sludge (BS) in an outpatient setting. The study included 115 patients who, according to the ultrasound revealed a BS. Own methodological approach used by ultrasound scan of the gall bladder and the interpretation of ultrasonographic BS types: Type 1 (suspension echo-positive particles) was set at 59.1%, type 2 (low level of mobile like putty echo-positive bile)--23.5%, 3 type (like putty bile in the form of mobile and/or fixed clots)--17.4%. For the treatment of BS used drugs ursodeoxycholic acid. The daily dosage depends upon the type BS. For the treatment of type 1 requires a minimum of 1 month, 2 types--not less than 3 months. Sludge was the most resistant type 3, which is the duration of treatment was 6-12 months or more. Allocation of risk factors forming the BS is the basis for the formation of risk groups and prevention activities (including pharmacotherapeutic).
authors.forename: O N
authors.initials: ON
authors.lastname: Manushkin
authors.forename: E G
authors.initials: EG
authors.lastname: Burdina
authors.forename: E V
authors.initials: EV
authors.lastname: Novozhenova
authors.forename: S A
authors.initials: SA
authors.lastname: Vasil'chenko
authors.forename: N Iu
authors.initials: NIu
authors.lastname: Gurova
mesh_terms: D000553:Ambulatory Care; D001646:Bile; D002756:Cholagogues and Choleretics / Q000008:administration & dosage*; D002779:Cholestasis / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy*; D005260:Female; D005704:Gallbladder / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D008875:Middle Aged; D014463:Ultrasonography; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage*
chemical_list: D002756:Cholagogues and Choleretics; D014580:Ursodeoxycholic Acid